Within the ET group, patients carrying JAK2 mutations exhibited iron-related and erythropoietic features that appeared closer to those typically seen in PV, including lower ferritin, TSI and EPO levels and higher Hb and Hct. This evidence concerns the gene EPO and acquired polycythemia vera.